GlassScriptPhysician profile
Lawrence A Lavery
NPI 1992765655
$59,442.44
in general payments reported to CMS, 2019-2025
30 companies · $9,516 in 2025
The $9,516 reported for 2025 was more than what 98% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,352 · 2020: $2,737 · 2021: $13K · 2022: $4,235 · 2023: $2,168 · 2024: $18K · 2025: $9,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $3,895 · Food and Beverage: $2,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,430.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,050.00 |
| Travel and Lodging | $3,894.85 |
| Food and Beverage | $2,437.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $10,645.95 | 2024 | Nuzyra |
| Inari Medical, INC. | $8,982.22 | 2024-2025 | Limflow System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kci USA, INC. | $8,482.14 | 2019-2020 | |
| Sanara Medtech INC. | $6,780.00 | 2023-2025 | |
| Integra Lifesciences Corporation | $5,572.36 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polarityte, INC. | $5,085.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $2,500.00 | 2020 | |
| Kerecis Limited | $2,092.82 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Alfasigma USA, INC. | $2,002.50 | 2021 | |
| Medela Ag | $2,000.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $1,635.00 | 2022 | |
| Cardinal Health 200 LLC | $1,050.00 | 2021 | |
| Smith+Nephew, INC. | $786.33 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Stryker Corporation | $374.98 | 2025 | Limflow System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Musculoskeletal Transplant Foundation INC. | $306.58 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $157.14 | 2022 | |
| Depuy Synthes Sales INC. | $140.47 | 2024 | Trumatch |
| Davol INC. | $125.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Ets Wound Care LLC | $107.83 | 2024 | Mirragen Advanced Wound Matrix |
| Derma Sciences, INC. | $104.46 | 2019 | |
| Abbvie INC. | $103.66 | 2023-2024 | |
| Polynovo North America LLC | $78.25 | 2024-2025 | Novosorb Btm |
| Next Science LLC | $71.09 | 2022 | |
| Biocomposites INC | $69.05 | 2025 | Stimulan |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.11 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Lavery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.